X4 PHARMACEUTICALS, INC Public Float
X4 PHARMACEUTICALS, INC (XFOR) had Public Float of $14.90 million as of 2025-06-30, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-17
- 2025-06-30: Entity Public Float $14.90M.
- 2024-06-30: Entity Public Float $96.00M.
- 2023-06-30: Entity Public Float $318.00M.
- 2022-06-30: Entity Public Float $29.60M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $14.90M 10-K · filed 2026-03-17 |
| 2024-06-30 | $96.00M 10-K · filed 2025-03-26 |
| 2023-06-30 | $318.00M 10-K · filed 2024-03-21 |
| 2022-06-30 | $29.60M 10-K · filed 2023-03-21 |
| 2021-06-30 | $158.00M 10-K · filed 2022-03-17 |
| 2020-06-30 | $144.75M 10-K · filed 2021-03-19 |
| 2019-06-30 | $183.72M 10-K · filed 2020-03-12 |
| 2018-06-29 | $27.04M 10-K · filed 2019-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |